Find Out Now What Should You Do For Fast Xarelto Lawsuit
Our attorneys have filed a mass tort lawsuit on behalf reversal of xarelto patients who took the blood thinner Xarelto (rivaroxaban) and suffered significant bleeding events. Pharmaceutical firms, which includes the makers of Xarelto, possess a duty to ensure that their drugs are reasonably secure for use - and failure to do so may be grounds for compensation. Our lawyers are operating challenging to obtain those hurt by the drug the compensation they are entitled to.
Although bleeding is actually a frequent complication associated with anticoagulants, it has been alleged that Xarelto is far more hazardous than traditional blood thinners simply because no antidote exists to reverse its blood-thinning effects. This means that, within the occasion of an emergency, sufferers might be at danger for irreversible bleeding issues, including life-threatening internal and gastrointestinal hemorrhaging.
In case you or a loved a single suffered a severe bleeding event following taking Xarelto, you might have legal recourse. For a lot more details, speak to us right now to possess your case reviewed, free of charge.
Compensation Possibilities
xarelto-compensation-photoThe plaintiffs in these lawsuits are looking for compensation from Bayer and Janssen for past and future healthcare bills, lost wages, pain and suffering and, in cases of death, funeral expenditures. In addition, they're looking for punitive damages, that are generally awarded to punish the defendant and deter other firms from acting similarly.
Why Are Lawsuits Becoming Filed?
Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is dangerous and defective. The plaintiffs claim that, unlike conventional anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Due to the fact of this, the lawsuits claim, doctors have no effective implies of stopping Xarelto users from bleeding in the event of an emergency. Plaintiffs inside the lawsuits allege serious and fatal injuries, such as cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.
In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:
The manufacturers of Xarelto marketed the drug as a superior within the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
The makers of the drug continue to market Xarelto as a protected anticoagulant option.
Doctors and healthcare staff were not properly made aware of methods to stabilize and treat a Xarelto user inside the occasion of a bleeding complication.
Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding occasion.
Xarelto is linked to significant bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing unsafe clotting.
Visit this page for far more details on the alleged health risks of Xarelto.
Multidistrict Litigation Trial Dates Set
The attorneys in the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.
